Biological characterics of human fetal cord blood mesenchymal stem cells

AIM: To investigate the biological characterics of human second-trimester fetal cord blood mesenchymal stem cells (MSC) and its application prospects in utero gene transfer/therapy (IUGT). METHODS: Nuclear cells separated from cord blood were cultured in DMEM medium. Surface antigens of the MSC were analyzed by the FACScan flow cytometry. Adipogenic and osteogenic mediums were used to assess the differentiation ability of the cells. Adenovirus vector deliver green fluorescent protein gene (Ad-GFP) was used to transfected the MSC and the expressing of GFP was detected by fluorescent microscope. The MSC were injected into the liver of newborn rat. The immunofluorescence analysis was conducted to determine the presence of double-positive CD105⁺/CD166⁺ cells in different organs of rats. MSC were subcutaneous injected into the human-nonobese diabetes/severe combined immunodeficiency disease (NOD/SCID) mice and carcinogenesises of the MSC in vivo were detected by pathological diagnosis. RESULTS: MSC could be separated from fetal cord blood. These cells were uniformly positive for CD29, CD44, CD59, CD105, CD166 and negative for CD34, CD45, CD80, CD86, HLA-DR. The cells had the abilities to differentiate into adipogenic and osteogenic cells in vitro, expressed the GFP at high levels (56.32%±3.28%). The MSC were located at different organs after injected into the newborn rats and didn't have carcinogenicity in vivo. CONCLUSION: Human second-trimester fetal cord blood MSC is an promising target cells in fetal IUGT.     

Osteogenic and neurogenic differentiation of human yolk sac mesenchymal stem cells

AIM: To purify human yolk sac mesenchymal stem cells (hYS-MSC) and investigate its osteogenic and neurogenic differentiation potentials. METHODS: hYS-MSC were separated from yolk sac and purified via passage culture. The karyotype of hYS-MSCs was analyzed via G-banded characteristics. Flow cytometric analysis was used to determine the cell cycle and phenotype of hYS-MSC. The AKP expression of hYS-MSC was also tested. Osteogenic differentiation of hYS-MSCs was induced by 10-8mol/L dexamethasone, 10 mmol/L β-glycerophosphate and 50 mg/L vitamin C. Alizarin red S stain was used for identification of mineralization. β-mecaptoethanol or salviae miltiorrhizae were used to induce neurogenic differentiation of hYS-MSCs. The expressions of NSE, NF and GFAP were identified by immunohistochemical method. RESULTS: hYS-MSCs could be purified at passages 2 or 3. The cell cycle analysis suggested that hYS-MSCs showed strong proliferational potentials by which the cells kept normal diploid karyotype during the in vitro culture. Flow cytometry showed the phenotype of purified hYS-MSCs was uniformly positive for CD29, CD44, CD105, and CD166, and negative for reactivity to antigens CD34, CD45, or CD86. hYS-MSCs were weakly but clearly positive in AKP. Osteogenic differentiation was appeared after induction of osteogenic differentiation. hYS-MSCs, which were of spindle shape, uniform in size, were induced to pleomorphism osteoblast-like cells which expressed high level of AKP. Aggregates or nodules were formed at day 7 and calcium accumulation was detected by alizarin red S staining on day 10 or day 14. Neurogenic differentiation of hYS-MSCs was induced by β-mecaptoethanol or salviae miltiorrhizae. NSE, NF or GFAP positive cells were detected by immunohistochemical staining. CONCLUSIONS: hYS-MSCs have strong proliferation potential and the normal diploid karyotype is kept during the in vitro culture. The phenotype of hYS-MSCs is coincident with adult hMSCs. hYS-MSCs could be induced to differentiate into osteogenic or neurogenic cells.     

Effects of rhTGF-β1 on proliferation and osteogenic differentiation of MSCs in SD rats

AIM：To investigate the effects of recombinant human transforming growth factor β1 (rhTGF-β1) on the ability of proliferation and osteogenic differentiation of rat bone marrow mesenchymal stem cells (MSCs), as well as its effects on the expression of bone morphogenetic protein 2 (BMP-2), Smad4 and core binding factor α1 (Cbfa1). METHODS：SD rat MSCs were isolated and purified by the differential time adherent method. MTT assay was used to confirm the optimal concentration of rhTGF-β1 for the proliferation of MSCs. The optimal concentration for differentiation of MSCs into osteoblast was also determined by observing the activity and positive staining of alkaline phosphatase. According to the different induction conditions, MSCs were divided into 4 groups:control group, classic group, rhTGF-β1 group, and rhTGF-β1+classic group. Alkaline phosphatase, type I collagen, bone Gla protein and calcium nodes were detected to evaluate the osteogenic differentiation. BMP-2 was detected by ELISA and the mRNA expression of Smad4 and Cbfa1 was analyzed by real-time quantitative PCR. RESULTS：The optimal concentrations of rhTGF-β1 for the proliferation of MSCs and for the osteogenic differentiation of MSCs were 10 and 5 μg/L, respectively. The MSCs in classical group and rhTGF-β1 group were promoted to osteogenic differentiation, and the mRNA expression of BMP-2, Smad4 and Cbfa1 was increased. rhTGF-β1 induced osteogenic differentiation of MSCs in the early and middle terms. However, in rhTGF-β1+classic group, the osteogenic differentiation of MSCs was more obvious in the late term. CONCLUSION:The induction conditions of classical group, rhTGF-β1 group and rhTGF-β1+ classical group promote the differentiation of MSCs by increasing BMP-2 secretion and starting the TGF-β superfamily/Smads signaling pathway to regulate the differentiation of MSCs.     

Effects of PD98059 on the differentiation from mesenchymal stem cells to osteoblasts

AIM: To investigate the effects of PD98059 on the differentiation from mesenchymal stem cells to osteoblasts.METHODS: hMSC were separated from human marrow and expanded in cuture medium. hMSC were induced with dexamethasone, β-glycerophosphate, vitamin C which acted as osteoblast differentiation inducer. PD98059 was added into the osteoblasts induction medium. The cells were assayed with cell morphology, alkaline phosphatase (AP) activity and calcium deposition. RESULTS: The isolated cultured MSC comprised a single phenotypic population and displayed a fibroblast-like morphology. After induced with osteoblasts induction medium, the cells showed changes in cell morphology from spindle-shape to cuboidal and polygonal. The AP activity increased gradually and reached the peak in 12 days, then decreased. Many scattered tangerice calcium nodes were observed. PD 98059 significantly inhibited AP activity and calcium deposition in a dose-dependent manner. A striking observation of the present study was that a few adipocytes appeared in cultures that were treated with PD 98059 and osteogenic differentiation medium. CONCLUSION: These results indicated that osteogenic diferentiation from the hMSCs was related to the activation of the ERK.     

Influence of maxadilan on human adipose-derived stem cells

AIM: To investigate the effect of maxadilan, which specifically activates pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1 receptor), on the proliferation, apoptosis and differentiation potential of human adipose-derived stem cells (ASCs). METHODS: ASCs from human adipose tissue were isolated by enzymatic digestion and cultured. ASCs were confirmed by the analysis of the markers for cell phenotypes by flow cytometry (FCM) and adipogenic/osteogenic induction. The effect of maxadilan on ASCs viability was analyzed by CCK-8 assay and FCM. ASCs were irradiated by ultraviolet C (UVC) at 254 nm and the absorbance of apoptotic ASCs induced by various doses of UVC was measured by CCK-8 assay. ASCs were exposed to 702 J/m² UVC for 24 h to induce apoptosis. The effect of maxadilan on ASC apoptosis was analyzed by FCM and the determination of caspase 3 and caspase 9 levels. RESULTS: Adipose-derived stem cells were confirmed by the detection of the positive expression of cell phenotypes including CD29, CD44, CD59 and CD105 by FCM. The data of CCK-8 assay revealed that ASCs treated with maxadilan (80 nmol/L) had the strongest ability of proliferation. The data of FCM also demonstrated that the addition of 80 nmol/L maxadilan to ASCs in experimental group markedly improved the proliferation capacity of the cells compared with control group (P<0.05). The apoptosis of ASCs exposed to 702 J/m² UVC was dramatically inhibited by the treatment with maxadilan (80 nmol/L). Such process involved the caspase signaling pathway including caspase 3 and caspase 9. There was statistical significance (P<0.05) between experiment group (ASCs irradiated by UVC and supplemented with maxadilan) and control group (ASCs only irradiated by UVC). Meanwhile, adipogenic and osteogenic differentiation potentials were both positive in experiment group and control group. CONCLUSION: Maxadilan promotes proliferation and inhibits apoptosis of the ASCs. The differentiation potential of ASCs toward adipogenic and osteogenic lineages wouldn't be altered by maxadilan. Maxadilan would benefit to growth and expansion of ASCs in vitro.     

Strontium ranelate promotes osteogenic differentiation of rat bone mesenchymal stem cells through TGF-β1/Smad signaling pathway

[ABSTRACT] AIM: To study the roles of transforming growth factor β1 (TGF-β1)/Smad signaling pathway in strontium ranelate (Sr)-induced osteogenic differentiation of rat bone marrow mesenchymal stem cells (BMSCs). METHODS: In the process of osteogenic differentiation of rat BMSCs, the expression of phosphorylated Smad2 (p-Smad2) and Runx2 was detected by Western blotting after the cells were treated with Sr. BMSCs were pretreated with SB431542, a selective inhibitor of TGF-β1, or Smad2 small interfering RNA (Smad2-siRNA), followed by Sr treatment, and then the expression of p-Smad2 and Runx2 was observed. At the same time, the activity of alkaline phosphatase (ALP) and the level of calcium nodules were detected to determine the osteogenic differentiation of BMSCs. RESULTS: The expression levels of p-Smad2 and Runx2 were enhanced under the action of Sr in the process of osteogenic differentiation of rat BMSCs. The expression of p-Smad2 reached to maximum when BMSCs were treated with Sr at concentration of 1 mmol/L for 1 h. The expression of Runx2 reached to maximum when BMSCs were treated with Sr at concentration of 1 mmol/L for 5 d. The pretreatment with SB431542 or Smad2-siRNA inhibited not only the expression of p-Smad2 and Runx2, but also the activity of ALP and the level of calcium nodules. CONCLUSION: Sr promotes the osteogenic differentiation of rat BMSCs through the TGF-β1/Smad signaling pathway.     

Differentiation of bone marrow mesenchymal stem cells into chondrocytes

AIM: To investigate the differentiation of human bone marrow mesenchymal stem cells (MSC) into chondrocytes in vitro and determine factors involving in the differentiation process. METHODS: MSC were separated from iliac bone marrow with lymphocyte separating medium using density centrifugation. Cells were cultured and expanded in medium until reaching required number. MSC was induced to differentiate into chondrocytes by adopting high cell density, supplying growth factor and using micromass culture. Cells were observed by HE staining. Matrix of cartilage was detected by alcian blue and toludine blue and cartilage specific collagen II was detected by immunohistochemistry. RESULTS: The structure of the micromass assumed that of cellular cartilage, alcian blue staining were uniformly positive and toludine blue detected diffuse metachromasia substance, cells uniformly expressed collagen Ⅱ. CONCLUSION: High cell density, growth factor and appropriate culture conditions are critical to induce differentiation of MSC into chondrocytes.     

《中国蔬菜品种志》

AIM: To characterize the gene expression of sortilin on adipogenic and osteogenic differentiation in mesenchymal stem cells (MSCs) in vitro and explore its significance.METHODS: MSCs derived from human bone marrow were isolated and cultured in vitro, then were stimulated in osteogenic medium and adipogenic medium, respectively. Osteopontin and lipoprotein lipase were detected by RT-PCR. Sortilin expression was analyzed by semiquantitative RT-PCR. RESULTS: 1.MSCs displayed the potential of differentiation into osteoblast and adipocyte. 2.Sortilin was upregulated one day after osteogenic induction and remained upregulated for a week. The expression of sortilin was significant increased on day 3(P＜0.01). 3. No significant changes of sortilin expression was found in adipogenic differentiation (P＞0.05).CONCLUSION: Sortilin may be useful to modulate the osteogenic differentiation and may not be necessary for adipocyte commitment in MSCs. The regulation of sortilin expression may provide new protocal and strategy for the treatment of osteoporosis and osteopenic disease.     

Effects of liquid crystal/PU composite substrate on osteogenic differentiation of rBMSCs

AIM: To explore the effect of the elastic modulus and sizes of liquid crystal (LC) phases on osteogenic differentiation based on OPC/PU composite substrate by mimicking the microenvironment in rat bone mesenchymal stem cells (rBMSCs). METHODS: A series of composite substrates with different elastic modulus were constructed via modulation of LC content in the composites. The surface phase structure was observed by polarized microscopy, and the mechanical property was measured by a universal material testing machine. Furthermore, the laser confocal microscope was employed to observe the spreading, polarization and the cytoskeleton arrangement of the rBMSCs. The proliferation of rBMSCs was evaluated by CCK-8 assay. The specific mRNA expression of osteogenic differentiation such as collagen Ⅰ, and osteopontin on the composite membranes was detected by real-time PCR. RESULTS: The size and number of LC phase increased and the elastic modulus of the composite substrates decreased with the increase of the LC content. The rBMSCs exhibited better characteristics of initial adhesion, spreading and proliferation on the OPC10-PU and OPC30-PU in the early and medium culturing. The rBMSCs displayed higher expression of collagen Ⅰ and osteopontin on the OPC10-PU in the early and medium osteogenic induction, while the high expression of these osteogenic genes occured on the OPC30-PU and OPC50-PU in later osteogenic induction. The emphasis of genetic expression was switched from collagen Ⅰ in the early and medium osteogenic induction to osteopontin in the later stage. CONCLUSION: When the content of LC remained low in the composite substrates, rBMSCs mainly responded to the mechanical stimuli induced by substrate stiffness and exhibited distinguished cellular behaviors; with the increase in the LC content, rBMSCs had strong interactions with LC by sensing the viscoelasticity of LC, probably resulted from the contribution of both substrate stiffness and the viscoelasticity of LC phase.     

Therapeutic action of transplantation of marrow mesenchymal stem cells into infarction area after cerebral middle artery occlusion in rats

AIM: To explore the differentiation and the functional behavior of marrow mesenchymal stem cells (MSC) transplanted into the cerebral infarction area after cerebral middle artery ischemia in rats. METHODS: MSC were isolated from human rib marrow and cultured in L DMEM medium in vitro. The model of rat cerebral infarction by cerebra middle artery occlusion was established, and the identified MSC were transplanted intracerebrally 10 days later. Immunohistochemistry technique was used to identify the cell survivor and its differentiation to the neurogenesis in the transplantation site, and at 2 weeks and 6 weeks after transplantation, the functional tests were comparatively studied. RESULTS: The results showed that the survivor of transplanted MSC was differentiated to neural phenotype cells, and the functional behavior of the injury rats was recovered significantly after MSC transplantation (P<0.05). CONCLUSION: Our data suggest that transplantation of MSC may be a powerful autoplastic therapy for the stroke.     

Human mesenchymal stem cells differentiate into neuron-like cells with Tanshinone II A

AIM:To investigate the differentiation from human mesenchymal stem cells(hMSC) into neuron-like cells with Tanshinone II A.METHODS:hMSC were separated from rib marrow with Ficoll-Paque reagent and expanded in culture medium. To detect the surface antigens, the labeled cells were analysed on a FACScan flow cytometer to determine the effect of the capacity of proliferation and differentiation of the mesenchymal stem cells with FGF-2. hMSC were induced to differentiate into neurons with DMEM Tanshinone II A. Neuron-specific enolase(NSE), neurofilament(NF), Nestin, glial fibrillary acaidic protein(GFAP) were detected by immunohistochemistry.RESULTS:hMSC were expanded as undifferentiated cells in culture for more than 15 passages. The isolated cultured MSC comprised a single phenotypic population and displayed a fibroblast-like morphology. These expanded attached MSC were uniformly positive for CD29, CD44, CD90, CD105, CD166 and didn't express CD11a, CD14, CD34, CD38, CD45, CD80, CD86. FGF-2 have special effect on low denisity MSCs. Simple methods with Tanshinone II A induced hMSC to exhibit a neuronal phenotype, expressing NSE, NF-M, Nestin at 5 hours. But the neuron-like cells didn't express the glial astrocyte marker GFAP.CONCLUSION:hMSC can be induced to differentiate into neurons with Tanshinone II A.     

Human mesenchymal stem cells differentiate into osteoblasts

AIM:To investigate the differentiation from human mesenchymal stem cells (hMSC) into osteoblasts. METHODS:MSC were separated from human marrow with Ficoll-Paque reagent and expanded in cuture medium. To detect the surface antigens, The labeled cells were analysed on a FACScan flow cytometer. hMSC were induced to differentiate from mesenchymal stem cells into osteoblasts with dexamethasone, vitamin C, β-GP. Cell morphology、AP activity、calcium deposition and osteopontin were detected. P10 MSC were compared to P3 MSC in the tendency of osteoblastic differentiation. RESULTS:The cultured MSC comprised a single phenotypic population and displayed a fibroblast-like morphology. hMSC showed a strong self-renewal capacity. After primary culture, approximately (5-6)×10⁵ cells were obtained. These expanded attached MSC were uniformaly positive for CD29,CD44,CD59,CD105,CD166 and didn’t express CD11a, CD14, CD33, CD34, CD45, CD38, CD80, CD86, CD117. After osteoblasts induction, the cells changed from spindle-shape to cuboidal and polygonal in cell morphology. The AP activity increased gradually and many scattered calcium nodes were observed. The expression of osteopontin was positive. CONCLUSION:hMSC can be induced to differentiate into osteoblasts.     

Interleukin-4 regulates phonotype,proliferation and hematopoietic supporting capacity of human umbilical cord mesenchymal stem cells

AIM: To explore the effects of interleukin-4 (IL-4) on the biological characteristics and hematopoietic supporting effects of umbilical cord mesenchymal stem cells (UC-MSC). METHODS: The phenotype of UC-MSC was detected by flow cytometry after IL-4 stimulation, and the proliferation ability of UC-MSC was measured by BrdU-ELISA. Oil red O and alizarin red were used to observe the ability of differentiation. The mRNA expression in UC-MSC was determined by real-time fluorescence quantitative PCR. The culture medium isolated from UC-MSC was used to analyze the ability in promoting colony formation.RESULTS: After IL-4 stimulation, the expression of CD11b, CD19, CD34, CD45, CD73, CD90, CD105, HLA-DR and HLA-ABC was unchanged. IL-4 inhibited the proliferation of UC-MSC, but no difference was detected on osteogenic and adipogenic differentiation. The culture medium from IL-4-induced UC-MSC possessed strong ability for promoting CD34+ colony formation ability. CONCLUSION: IL-4 inhibits the proliferation of UC-MSC and enhances its hematopoietic supporting ability.     

Effects of different HA/ZrO2 composites on adherence,proliferation and osteogenesis of cultured MSCs

AIM: To study the adherence, proliferation and osteogenesis effects of different composites on cultured mesenchymal stem cells (MSCs). METHODS: Zirconium oxide (ZrO₂) with monolayer hydroxyapatite (HA) composite and ZrO₂ with gradient HA composite were prepared using dry-laying method. The surface topography of the composites was observed. The rabbit MSCs were isolated and cultured on HA/ZrO₂ monolayer composite, HA/ZrO₂ gradient composite, pure HA or pure ZrO₂ slices. The adherence, proliferation and osteogenesis of the MSCs were assayed. The activity of alkaline phosphatase was detected. The mRNA expression of collagen I, osteocalcin and osteopontin was determined by RT-PCR. RESULTS: The discontinuous or continuous HA surface was observed in HA/ZrO₂ monolayer composite,while the surface of prepared HA/ZrO₂ gradient composite was fairly rough with porosity. The X-ray diffraction analysis shows that after megatemperature sintering, the ZrO₂ phase on the surface of the composite still remained, while the HA phase transformed to β-Ca₃(PO₄)₂(β-TCP), α-Ca₃(PO₄)₂(α-TCP) and CaZrO₃ phases. Cell culture showed that the HA/ZrO₂ gradient composite was in favour of cell adherence. The alkaline phosphatase activity in MSCs on pure HA slice was significantly increased compared compared with other groups.The mRNA expression of collagen I, osteocalcin and osteopontin in MSCs on HA/ZrO₂ composites and pure HA silice was higher than that in control group,especially the expression of collagen I. CONCLUSION: The HA/ZrO₂ garded composite promotes the proliferation of MSCs to a certain extent, and also promotes the osteogenesis differentiation of MSCs.     

Proliferation and differentiation patterns of hematopoietic precursor from umbilical blood in mesenchymal stem cell microenvironment

AIM: To investigate the proliferation and differentiation patterns of hematopoietic precursors from cord blood in mesenchymal stem cell(MSC) microenvironment. METHODS: MSC was used as feeder cells, the mononuclear cells (MNCs) from cord blood were expanded in MSC microenvironment in the presence of stem cell factor(SCF), FMS-like tyrosine kinase 3 ligand(Flt3L), thrombopoietin (TPO) and IL-6. MNC count and colony-forming cell(CFC) culture were performed at week 1, 2, 3 and 4. RESULTS: (1) The number of MNCs increased and reached 108-fold in group MSC+CK(cytokine), but 7.8-fold in group CK at week 4. (2) CFC increased and reached the peak at week 3, the total number of CFC was higher in group MSC+CK than that in group CK, a rapid decline was observed at week 4. (3) The greatest expansion of erythroid CFC and high proliferative potential colony-forming cells(HPP-CFC) occurred at week 1, went down rapidly and dropped to zero at week 3, expansions in group MSC+CK were greater than that in group CK. (4) Myeloid CFC expanded continuously and the greatest expansion occurred at week 3, and declined at week 4. Myeloid CFC expanded greater in group MSC+CK than that in group CK. (5) CFC number per 104 MNCs reached the peak after one week of expansion, then declined rapidly from week 2, and dropped lower than that before expansion by the end of week 4.CONCLUSION: (1) Expansion ability of hematopoietic precursors from cord blood in MSC microenvironment is better than that in culture system without MSC. (2) Even expansion is performed in MSC microenvironment, differentiation could not be prevented. (3) Expansion of erythroid precursors occurrs in the early stages of ex vivo expansion. Expansion of myelomonocytic precursors lasts longer than that of erythroid.     

The roles of ERK signaling pathway in osteogenic differentiation of rat MSCs promoted by quercetin

AIM:To study the roles of extracellular signal-regulated kinase(ERK) signal pathway in the process of osteogenic differentiation in rat mesenchymal stem cells(MSCs) promoted by quercetin(QUE). METHODS:The optimal concentration of QUE for promoting osteogenic differentiation of rat MSCs was determined by MTT and alkaline phosphatase(ALP) detection. The activity of ALP was detected by the ALP detection kit. The expression of bone Gla protein(BGP) and collagen typeⅠ(ColⅠ) was observed by ELISA analysis. MSCs were exposed to QUE at optimal concentration with or without ERK1/2 inhibitor PD98059. Non-phosphorylated and phosphorylated expression of ERK1/2 was analyzed by Western blotting. The mRNA expression of transforming growth factor β₁(TGF-β₁), bone morphogenetic protein 2(BMP-2) and core binding factor α1(Cbfα1) was measured by fluorescence quantitative PCR. RESULTS:QUE at concentrations of 0.1 μmol/L, 1 μmol/L and 10 μmol/L induced the expression of ALP in MSCs in a dose-dependent manner, and also promoted MSCs proliferation. The expression levels of ALP, BGP and ColⅠwere higher in QUE group, and was lower in PD89059 group than those in control group. Compared with control group, the level of phosphorylated ERK1/2, and the mRNA expression of TGF-β₁, BMP-2 and Cbfα1 increased in QUE group. The mRNA expression of TGF-β₁, BMP-2 and Cbfα1 in QUE+PD98059 group decreased as compared with QUE group. CONCLUSION:QUE promotes osteogenic differentiation of MSCs by activating ERK signaling pathway.     

Adult human mesenchymal stem cell differentiates into adipocytes

AIM:To investigate the differentiation from human mesenchymal stem cells (hMSC) to adipocytes.METHODS: hMSC were separated from rib marrow and expanded in culture medium. To detect the surface antigens, the labeled cells were analysed on a FACScan flow cytometer. hMSC were induced with dexamethasone, insulin, 1-methy1-3-isobutylxanthine and indomethacin which acted as adipocyte differentiation inducer. The cells were stained with Oil Red O. The number of adipocytes were counted on a phase-contrast microscope.RESULTS: hMSC were expanded as undifferentiated cells in culture for more than 5 passages. The isolated cultured MSC comprised a single phenotypic population and displayed a fibroblast-like morphology. These expanded, attached MSC were uniformly positive for CD29, CD44, CD90, CD105, CD166 and didn't express CD14, CD34, CD45, CD11a. After induced with induction medium, lipid vacuoles were first detectable within the cells at 48 hours. Two weeks later, more than 85% MSC differentiated into adipocytes which displayed a perinuclear accumlation of lipid vacuoles, as detected by Oil Red O. CONCLUSION:hMSC can be induced to differentiate into adipocytes.     

Inhibitory effect of IGF-1 overexpression on oxidative damage in umbilical cord mesenchymal stem cells

AIM: To analyze the inhibitory effect of insulin-like growth factor-1 (IGF-1) overexpression in umbilical cord mesenchymal stem cells (UC-MSCs) on oxidative damage and to develop new application model for UC-MSCs. METHODS: UC-MSCs were isolated from human umbilical cord with enzymatic digestion, and further characte-rized with flow cytometry. IGF-1-overexpressing UC-MSCs (UC-MSCs-IGF-1) were established by retrovirus infection. IGF-1 expression of UC-MSCs-IGF-1 was evaluated by real-time quantitative PCR and flow cytometry, and its surface markers, as well as osteogenic and adipogenic differentiation ability, were further analyzed. The proliferation, anti-oxidative damage and anti-apoptosis abilities of UC-MSCs-IGF-1 were evaluated when treated with H₂O₂ at different concentrations (0 μmol/L, 10 μmol/L, 50 μmol/L and 100 μmol/L). RESULTS: UC-MSCs showed positive expression of CD29, CD90 and CD105, but negative expression of CD34, which coincided with the normal phenotype of mesenchymal stem cells. UC-MSCs-IGF-1 established with retrovirus infection showed much higher expression of IGF-1 compared with normal UC-MSCs, and expressed the same surface markers as UC-MSCs.The osteogenic and adipogenic differentiation abilities were also observed. With the oxidative damage by H₂O₂ treatment, UC-MSCs-IGF-1 showed more strong proliferation, anti-oxidative damage and anti-apoptosis abilities as compared with normal UC-MSCs. In addition, the activity of SOD in UC-MSCs-IGF-1 was a little higher than that in control group. CONCLUSION: IGF-1 overexpression in UC-MSCs inhibits oxidative damage and cell apoptosis. UC-MSCs-IGF-1 may have more advantagies in clinical application.     

Aged bone marrow stem cells can be rejuvenated by cell fusion with young bone marrow stem cells

AIM: To investigate the function of aged bone marrow mesenchymal stem cells (BMSCs) fused with young BMSCs in mice. METHODS: The cell fusion model, which was made by C57BL/6 mouse BMSCs labeled with PKH26 membrane red fluorescence (young cells, age of 2-3 months, Y) and (old cells, age of 18-24 months, O), and young and old BMSCs of green fluorescent protein (GFP) transgenic C57BL/6 mouse, was established by the induction of polyethylene glycol 1500 (PEG 1500). The cell fusion rate and cell surface markers were detected by flow cytometry. The morphology and nuclear characteristics of the fused cells were observed under fluorescence microscopy. In this study, the age dependent changes in BMSCs proliferation and differentiation potential in Y group, O group, and another three fusion groups (Y-Y group, Y-O group, O-O group) were examined. The proliferation potentials in 5 groups were compared by counting cell numbers at days 2, 4, 6, and 8. The osteogenic and adipogenic differentiation potentials of the cells in 5 groups were determined by using standard differentiation procedures. RESULTS: The fusion rate of 30.45%±4.13% was obtained by PEG 1500 induction. No significant difference of the fusion rates in Y-Y, Y-O and O-O groups was observed. Fused BMSCs coincided with the common BMSCs were reactive to the BMSCs lineage-specific CD44, Sca-1 surface markers and negative for the hematopoietic stem cells (HSCs) lineage-specific surface markers such as CD34, CD117, CD31, and CD45. The percentage of increasing cell numbers in Y-O group was significantly higher than that in O-O group at days 2, 4, 6, and 8. The positive rate of the area stained with Alizarin red, which represents osteogenic differentiation potential of BMSCs, was significantly higher in Y-O group than that in O-O group ［(25.46%±1.52%) vs (13.85%±1.69%), P<0.01］. In Y-O group, the higher rate of the positive area stained with oil red O, which represents adipogenic differentiation potential of BMSCs, was observed as compared to that in O-O group ［(12.99%±2.61%) vs (6.03%±1.71%), P<0.05］. CONCLUSION: Aged bone marrow stem cells can be rejuvenated by cell fusion with young bone marrow stem cells, particularly the proliferation and differentiation potentials.